Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: McGill_2013_Diabetes.Care_36_237

Reference

Title: Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study
McGill JB, Sloan L, Newman J, Patel S, Sauce C, von Eynatten M, Woerle HJ
Ref: Diabetes Care, 36:237, 2013 : PubMed

        



Related information

Inhibitor | Linagliptin,


Citations formats

McGill JB, Sloan L, Newman J, Patel S, Sauce C, von Eynatten M, Woerle HJ (2013)
Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study
Diabetes Care 36: 237-44

McGill JB, Sloan L, Newman J, Patel S, Sauce C, von Eynatten M, Woerle HJ (2013)
Diabetes Care 36: 237-44



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer